SCHEMBL335305

SCHEMBL335305

CC(=O)c1nccnc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 3/20 0.35
MAPT P10636 2/20 0.35
P2RX7 Q99572 1/20 0.34
PRKCI P41743 1/20 0.33
KMT2A Q03164 1/20 0.33
BRD4 O60885 1/20 0.32
MYC P01106 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
AHR P35869 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
DYRK1A Q13627 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
IKBKB O14920 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364216 1.00 SMN1; SMN2 (0.39) SMN1; SMN2PDE3BPDE3AALDH1A1KDM4E
SCHEMBL277948 0.87 PDE3B (0.45) SMN1; SMN2PDE3BPDE3AALDH1A1KDM4E
SCHEMBL5518273 0.82 KDM4E (0.36) SMN1; SMN2ALDH1A1KDM4EMAPTP2RX7
Benzyl Alcohol SCHEMBL29095963 0.80 KMT2A (0.46) SMN1; SMN2ALDH1A1KDM4EMAPTP2RX7
SCHEMBL23864829 0.80 KDM4E (0.35) SMN1; SMN2ALDH1A1KDM4EMAPTP2RX7
SCHEMBL29526925 0.80 KDM4E (0.47) ALDH1A1KDM4EMAPTKMT2AMYC
SCHEMBL287450 0.80 KDM4E (0.47) ALDH1A1KDM4EMAPTKMT2AMYC
SCHEMBL2310300 0.78 MKNK1 (0.42) ALDH1A1KDM4EMAPTP2RX7PRKCI
SCHEMBL23032651 0.78 KDM4E (0.34) SMN1; SMN2ALDH1A1KDM4EMAPTP2RX7
SCHEMBL1463944 0.78 MKNK1 (0.42) ALDH1A1KDM4EMAPTP2RX7PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4672967-A2 ALTERNATIVE COFFEE BEVERAGES Compound Foods Inc. (US) 2026-01-07 EP claimed
US-20250120413-A1 ALTERNATIVE COFFEE BEVERAGES COMPOUND FOODS INC (US) 2025-04-17 US claimed
CN-116268351-B Hazelnut-flavor essence base material and preparation method and application thereof 湖南嘉利香料有限公司 2025-02-18 CN claimed
CN-119081799-A Photoresist cleaning solution and preparation method and application thereof 上海盛剑微电子有限公司 2024-12-06 CN claimed
CN-118914433-A Method for simultaneously separating multiple groups of isomers and quantitatively detecting 24 pyrazine compounds 泸州品创科技有限公司 2024-11-08 CN claimed
CN-118852032-A Alpha, beta-unsaturated ketone derivative, preparation method and application thereof 赣南医科大学 2024-10-29 CN claimed
CN-118684630-A Pyrazine polymer derivative and preparation method and application thereof 赣南医科大学 2024-09-24 CN claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 US claimed
WO-2024182557-A2 ALTERNATIVE COFFEE BEVERAGES COMPOUND FOODS INC. (US) 2024-09-06 WO claimed
CN-118518775-A Method for distinguishing single nectar from mixed nectar 汉中市食品药品监督检验检测中心(陕西省茶叶产品质量监督检测中心) 2024-08-20 CN claimed
WO-2014093819-A2 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2014-06-19 WO claimed
WO-2014010791-A1 SCENT COMPOSITION FOR FEED LIM SEUNG WOOK (KR) 2014-01-16 WO claimed
WO-2013171535-A2 AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES KAO CORPORATION (JP) 2013-11-21 WO claimed
WO-2013135511-A1 N-(2,4-DIMETHYLPENTAN-3-YL)-METHYLBENZAMIDES AND THEIR USE AS FLAVORING AGENTS IMAX DISCOVERY GMBH (DE) 2013-09-19 WO claimed
US-20130210775-A1 AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES KAO CORPORATION (JP) 2013-08-15 US claimed
WO-2013119312-A1 METHOD OF IDENTIFYING AN AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES KAO CORPORATION (JP) 2013-08-15 WO claimed
US-20130210022-A1 METHOD OF IDENTIFYING AN AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES KAO CORPORATION (JP) 2013-08-15 US claimed
CN-102797043-A Medicinal molecular fragment library and construction method thereof CBB NETWORK CO LTD 2012-11-28 CN claimed
CN-101494999-A Method for using organic compound GIVAUDAN SA (CH) 2009-07-29 CN claimed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210775-A1 AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES OR10J3, OR51E2, TAS2R5 SMN1; SMN2 4737/4885PDE3B 2145/4885PDE3A 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.